Economic Impact of Respiratory Syncytial Virus-Related Illness in the US L. Clark ParamoreVincent CiurylaLarry Liu Original Research Article 22 September 2012 Pages: 275 - 284
Longitudinal versus Cross-Sectional Methodology for Estimating the Economic Burden of Breast Cancer C. Daniel MullinsJunling WangClaudia R. Baquet Original Research Article 22 September 2012 Pages: 285 - 291
How Often Do Sensitivity Analyses for Economic Parameters Change Cost-Utility Analysis Conclusions? Bruce R. SchackmanHeather Taffet GoldPeter J. Neumann Original Research Article 22 September 2012 Pages: 293 - 300
Pharmacoeconomic Analysis of Amphotericin B Lipid Complex versus Liposomal Amphotericin B in the Treatment of Fungal Infections Joseph L. KutiSrividya KotapatiDavid P. Nicolau Original Research Article 22 September 2012 Pages: 301 - 310
Cost Effectiveness of Representatives of Three Classes of Antidepressants Used in Major Depression in the UK Alan Lenox-SmithPete ConwayChris Knight Original Research Article 22 September 2012 Pages: 311 - 319
Cost Effectiveness of Combination Therapy with Pioglitazone for Type 2 Diabetes Mellitus from a German Statutory Healthcare Perspective Kurt NeeserGeorg LübbenWendelin Schramm Original Research Article 22 September 2012 Pages: 321 - 341